Etoposide (1 μg/mL) was used as a positive control. The number of cells in both the control and treated cell samples were estimated based on their total nucleic acid content, as described by Cingi et al. (1991). Cells were seeded at 5 × 104 cells/well in 96-well tissue culture plates and exposed to different concentrations of ConA or ConBr lectins (1–200 μg/ml) dissolved Inhibitor Library solubility dmso in the RPMI medium (with 1% FBS).

After 72 h of incubation, cells were fixed (5% trichloroacetic acid), washed twice with ice-cold PBS, and a soluble nucleotide pool was extracted with cold ethanol. The cell pellet was dissolved in 0.5 M NaOH at 37 °C overnight. Following this, the absorbance at 260 nm of the NaOH fraction was used as an index of the cell number (Bianchi and Fortunati, 1990). The results are expressed as mean percentages of absorbance at 260 nm in treated cells compared to the controls. Etoposide (1 μg/ml) was used as a positive control. In MTT and NAC assays the concentration AG-014699 price that inhibits 50% of cell proliferation (IC50) was determined from plots of cell viability. Proliferating cells can be identified using DNA labeling with nucleotide analogs such as bromodeoxyuridine (BrdU). Leukemic cells were plated in 24-well tissue culture plates (0.3 × 106 cells/mL) and treated with lectins at different concentrations dissolved in RPMI medium (with 1% FBS). After 21 h of exposure, 20 μl of BrdU (10 mM) was added

to each well and incubated for 3 h at 37 °C. To determine the amount of BrdU incorporated into DNA (Pera et al., 1977), cells were harvested and then transferred to cytospin slides and allowed to dry for 2 h at room temperature. Cells that had incorporated BrdU were Amrubicin labeled by direct peroxidase immunocytochemistry using the chromogen diaminobenzidine (DAB). Slides were counterstained with hematoxylin, mounted, and coverslipped. Determination of BrdU positivity was performed by light microscopy (Olympus, Tokyo, Japan). Two hundred cells were counted per sample to determine the percentage of BrdU-positive

cells. Etoposide (1 μg/ml) was used as a positive control. The comet assay, which is used to detect DNA strand breaks, was conducted under alkaline conditions as described by Singh et al. (1988) with minor modifications (Klaude et al., 1996) following the recommendations of the International Workshop on Genotoxicity Test Procedures (Tice et al., 2000). HL-60 and MOLT-4 (0.3 × 106 cells/ml) cells were incubated for 24 h with lectins at 5, 25, and 50 μg/ml. After this, the cells were centrifugated and resuspended in the medium. Subsequently, 20 μl of the cells in suspension (∼106 cells/ml) were dissolved in 0.75% low melting point agarose and immediately spread onto a glass microscope slide precoated with a layer of 1% normal melting point agarose. The agarose was allowed to set at 4 °C for 5 min. The slides were incubated in an ice-cold lysis solution (2.